Raymond James Financial Inc Roivant Sciences Ltd. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Raymond James Financial Inc holds 84,091 shares of ROIV stock, worth $914,069. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84,091Holding current value
$914,069% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
324Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$717 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$715 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$588 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$453 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$384 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.66B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...